(Date:11/25/2009)...ALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,al...oilsandsoftwareandCalgaryScientificInc.,aleadingpr...dawebversionofAegis(TM)Breast4DAdvancedVisualizati...ttrulyzero-footprintWebclientbasedmedicalimagingof...atformallowsforzero-footprintaccess-requiringnosof...
(Date:11/25/2009)...Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInstitu...xecutiveleadershipfor2010. ,, ThenewBoardMember...ublicpolicy,law,finance,governmenthealthprograms,e...omesfromawiderangeofpersonalbackgroundsincludingbo...hHIVthemselves,andrepresentingmultipleagegroups. ,...
(Date:11/25/2009)...found evidence of a statistically significant surv...s whose estrogen receptor (ER)-positive tumors had...rine-118 (ER-alpha S118-P), according to a brief c...Journal of the National Cancer Institute . , App...to tamoxifen. Preclinical studies have shown that ...
(Date:11/25/2009)...used to fight rheumatoid arthritis, could help new...WEDNESDAY, Nov. 25 (HealthDay News) -- A drug comm...matoid arthritis now also shows some promise in he...s. , The drug, rituximab (Rituxan), helped pati...n though the disease had destroyed some of their p...
(Date:11/25/2009)...te, CDC sees few signs of trouble with the H1N1 va...y News) -- The ongoing H1N1 swine flu pandemic may... among younger patients, a U.S. health official sa...erious pneumococcal infections around the country,...er for Immunization and Respiratory Diseases at th...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiont...kihasaddedPhiladelphiajurorstoherThanksgivinggrati...oice.Iamsothankfultothem,"shesaidofMonday,sverdict...ticals. ,, Wisneskiisamong12,000womennationwide...hehormonetherapydrugsPremarinandPrempro.Wisneskian...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Maryland Woman Thankful for Wyeth Verdicts 2Clemson research nets 242 million from NSF to mimic natures probes 9738 1Clemson research nets 242 million from NSF to mimic natures probes 9738 2Bioavailable contaminants come from the Exxon Valdez oil catastrophe 9736 1Bioavailable contaminants come from the Exxon Valdez oil catastrophe 9736 2ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Clinical Trial Results to be Presented 4922 2...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6ThermoBrite
...trifuge with swinging bucket rotor. ,The MicroPr...h a swinging bucket rotor and optional fixed angle...y of clinical, biomedical, industrial, and biotech...ormation of a "swinging bucket centrifuge in a sma...
..., quiet, high-speed centrifuge. It employs a uniqu...esults in nearly vibration- free operation. Light ...d full breaking in a few seconds. Rotors can easil...sforming the centrifuge from Hematocrit to Urine S...
Silicone Foley
Medicine Products: